Shattuck Labs, Inc. (OTC:STTK)
Industry: Services

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Current Quote*
Last: $7.375
Change: 0.000
Book: $0.404
Volume: 880,937

As Of: 04/09 16:04 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol STTK

Graphs for STTK


3 Month Graph


6 Month Graph


1 Year Graph